tiprankstipranks

Daron Evans Insider Profile

4 Followers
Daron Evans, CEO of Specialty Renal Product at Nephros, holds 232.90K shares in Rezolute (Ticker: RZLT), holds 160.42K shares in Nephros (Ticker: NEPH). Most recently, Daron Evans Bought ― shares of Rezolute on Dec 18, 2024 for an estimated value of 42.90K.
tipranks
Daron Evans

Daron Evans
Nephros (NEPH)
CEO of Specialty Renal Product

Ranked #1,354 out of 99,797 Corporate Insiders

Profitable Transactions

75%
9 out of 12 Profitable Transactions

Average Return

+54.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
80.54%
19.46%
A breakdown of Daron Evans's holdings

Insider Roles

Rezolute
(RZLT)
CFO
Nephros
(NEPH)
CEO of Specialty Renal Product
Roles that Daron Evans holds in companies

Most Profitable Insider Trade

Stock:
Rezolute
(RZLT)
Rating:Informative Buy
Date:Feb 20, 2024 - Today
Return:+257.20%
The most profitable trade made by Daron Evans

Daron Evans's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Nephros
May 25, 2021
CEO of Specialty Renal Product
Informative Buy
6.00K
$247.04K
Rezolute
Dec 18, 2024
CFO
Informative Buy
42.90K
$1.02M
List of latest transactions for each holding click on a transaction to see Daron Evans's performance on stock

Daron Evans insider profile FAQ

What is the percentage of profitable transactions made by Daron Evans?
The percentage of profitable transactions made by Daron Evans is 75%.
    What is the average return per transaction made by Daron Evans?
    The average return per transaction made by Daron Evans is 54.40%.
      What stocks does Daron Evans hold?
      Daron Evans holds: NEPH, RZLT stocks.
        What was Daron Evans’s latest transaction?
        Daron Evans latest transaction was an Informative Buy of $42.90K.
          What was Daron Evans's most profitable transaction?
          Daron Evans’s most profitable transaction was an Informative Buy of RZLT stock on February 20, 2024. The return on the trade was 257.20%.
            What is Daron Evans's role in Nephros?
            Daron Evans's role in Nephros is CEO of Specialty Renal Product.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.